Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of clonidine, bisoprolol, tranexamic acid and gabapentin on bleeding and hemodynamics in rhinoplasty
IRCT20210415050976N11Phase 2Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clonidine, bisoprolol, tranexamic acid and gabapentin in None (4 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoints: Intraoperative bleeding rate, Hemodynamic stability and 1 more. Started May 2022; status: completed.
02
Drugs
clonidinebisoprololtranexamic acidgabapentin
Beyond the preview
Go deeper on IRCT20210415050976N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N11.